NCT03955640 - Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

October 15, 2022

Study Completion Date

October 31, 2023

Conditions

Metastatic Malignant Neoplasm in the Chest WallRecurrent Breast Carcinoma

Interventions

DRUG

Olaparib

Given PO

PROCEDURE

Hyperthermia Treatment

Undergo hyperthermia treatment

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (1)

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia